Shenzhen cell Valley to add an invention patent certificate!
Recently, our company was again awarded an invention patent issued by the State Intellectual Property Office, the name of which is "targeted BCMA chimeric antigen receptor and its application". The patent application was made on March 8,2023. After one and a half years of strict examination and uation, it was finally officially authorized by the State Intellectual Property Office on December 24,2024.
In the past two years, Shenzhen Cell Valley has applied for more than 20 patents, including 5 valid patents, 2 invention patents and 3 utility model patents.
These patent achievements reflect our company's research and development strength and innovation ability in the field of cell and gene therapy, and provide a solid technical support for the company's sustainable development and industry competitiveness. Shenzhen Cell Valley will continue to promote the transformation and application of scientific and technological achievements and contribute to the cause of human health.
These patent achievements reflect our company's research and development strength and innovation ability in the field of cell and gene therapy, and provide a solid technical support for the company's sustainable development and industry competitiveness. Shenzhen Cell Valley will continue to promote the transformation and application of scientific and technological achievements and contribute to the cause of human health.
